STOCK TITAN

Vanguard Group discloses 6.76% Sotera Health (SHC) stake in 13G/A

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 19,228,375 shares of Sotera Health Co common stock, representing 6.76% of the class as of 12/31/2025.

Vanguard reports no sole voting or dispositive power, with shared voting power over 1,574,791 shares and shared dispositive power over 19,228,375 shares. The filing explains that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries or business divisions that are deemed beneficial owners are expected to report holdings separately on a disaggregated basis while pursuing the same investment strategies as before.

The shares are held for Vanguard’s clients, including registered investment companies and other managed accounts, which have rights to dividends and sale proceeds. Vanguard certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of Sotera Health.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. As of that date, The Vanguard Group, Inc. no longer performs portfolio management services or administers proxy voting. In accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. anticipates that certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that currently have, or are deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:01/30/2026

FAQ

What percentage of Sotera Health (SHC) does The Vanguard Group report owning?

The Vanguard Group reports beneficial ownership of 6.76% of Sotera Health’s common stock. This corresponds to 19,228,375 shares as of December 31, 2025, making Vanguard a significant institutional shareholder above the 5% reporting threshold.

How many Sotera Health (SHC) shares does Vanguard have voting and dispositive power over?

The Vanguard Group reports shared voting power over 1,574,791 shares and shared dispositive power over 19,228,375 shares. It reports no sole voting power and no sole dispositive power over Sotera Health common stock in this filing.

Why did Vanguard mention an internal realignment in the Sotera Health (SHC) 13G/A?

Vanguard notes that on January 12, 2026 it underwent an internal realignment and no longer performs portfolio management or proxy voting. Certain subsidiaries or divisions are expected to report beneficial ownership separately on a disaggregated basis under SEC guidance.

Who ultimately benefits from the Sotera Health (SHC) shares held by The Vanguard Group?

Vanguard states that its clients, including registered investment companies and other managed accounts, have the right to receive dividends and sale proceeds from the Sotera Health shares. No single other person’s interest in these securities exceeds 5% of the class.

Is The Vanguard Group seeking to influence control of Sotera Health (SHC)?

Vanguard certifies the Sotera Health shares were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Sotera Health, consistent with passive institutional ownership reporting under Schedule 13G.

What type of SEC filing did Vanguard submit for its Sotera Health (SHC) position?

The Vanguard Group submitted an Amendment No. 2 to Schedule 13G for Sotera Health common stock. This filing updates its beneficial ownership disclosure as of December 31, 2025, including voting and dispositive power details and its internal realignment disclosure.
Sotera Health Co

NASDAQ:SHC

SHC Rankings

SHC Latest News

SHC Latest SEC Filings

SHC Stock Data

5.20B
220.60M
2.46%
89.45%
3.99%
Diagnostics & Research
Services-misc Health & Allied Services, Nec
Link
United States
BROADVIEW HEIGHTS